Literature DB >> 7698837

Ultrastructure of Borrelia burgdorferi after exposure to benzylpenicillin.

M Schaller1, U Neubert.   

Abstract

The aim of this study was to investigate the morphological changes of Borrelia burgdorferi associated with penicillin treatment. An isolate of B. burgdorferi from an erythema migrans lesion was cultivated in BSK II medium and exposed to increasing concentrations (0.0625 mg/l-2 mg/l) of penicillin G for 5 days. The in vitro minimal inhibitory concentration (MIC) was determined to be 0.5 mg/l by broth dilution method. The morphological structures of untreated spirochetes, as well as their characteristic ultrastructural changes when exposed to penicillin, were observed by electron microscopy. The following alterations were discovered: (i) Numerous outer sheath blebs at a penicillin concentration of 0.0625 mg/l. (ii) A characteristic irregular waveform of the borrelial cells and complete loss of the outer sheath at a penicillin concentration of 0.125 mg/l. (iii) The presence of "spheroplasts" at the same concentration. (iv) Structural changes of the protoplasmic cylinder complex which showed an irregular pattern at a penicillin concentration of 0.125 mg/l. (v) Disruption of the protoplasmic cylinder complex into several parts at penicillin concentrations of 0.25 mg/l and 0.5 mg/l. (vi) Severe cytolysis at penicillin concentrations of 1 mg/l and 2 mg/l.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7698837     DOI: 10.1007/bf01715497

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  18 in total

1.  Electron microscopic studies of the morphology of pathogenic spirochaetes.

Authors:  R H SWAIN
Journal:  J Pathol Bacteriol       Date:  1955 Jan-Apr

2.  Vaccination of hamsters against experimental infection with Borrelia burgdorferi.

Authors:  R C Johnson; C L Kodner; M E Russell
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1986-12

3.  New chemotherapeutic approaches in the treatment of Lyme borreliosis.

Authors:  B J Luft; D J Volkman; J J Halperin; R J Dattwyler
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

4.  Relation between excreted lipopolysaccharide complexes and surface structures of a lysine-limited culture of Escherichia coli.

Authors:  K W Knox; M Vesk; E Work
Journal:  J Bacteriol       Date:  1966-10       Impact factor: 3.490

5.  In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: a microdilution MIC method and time-kill studies.

Authors:  L L Dever; J H Jorgensen; A G Barbour
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

6.  Peptidoglycan of free-living anaerobic spirochetes.

Authors:  R Joseph; S C Holt; E Canale-Parola
Journal:  J Bacteriol       Date:  1973-07       Impact factor: 3.490

7.  In vitro and in vivo susceptibility of the Lyme disease spirochete, Borrelia burgdorferi, to four antimicrobial agents.

Authors:  R C Johnson; C Kodner; M Russell
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

8.  In vitro activity of vancomycin against the spirochete Borrelia burgdorferi.

Authors:  L L Dever; J H Jorgensen; A G Barbour
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

9.  Susceptibility of the Lyme disease spirochete to seven antimicrobial agents.

Authors:  S E Johnson; G C Klein; G P Schmid; J C Feeley
Journal:  Yale J Biol Med       Date:  1984 Jul-Aug

10.  Isolation and cultivation of Lyme disease spirochetes.

Authors:  A G Barbour
Journal:  Yale J Biol Med       Date:  1984 Jul-Aug
View more
  7 in total

Review 1.  A systematic review of Borrelia burgdorferi morphologic variants does not support a role in chronic Lyme disease.

Authors:  Paul M Lantos; Paul G Auwaerter; Gary P Wormser
Journal:  Clin Infect Dis       Date:  2013-12-12       Impact factor: 9.079

2.  beta-lactam antibiotics in the treatment of neuroborreliosis in children: preliminary results.

Authors:  M M Millner; G H Thalhammer; P Dittrich; K D Spork; M Brunner; A Georgopoulos
Journal:  Infection       Date:  1996 Mar-Apr       Impact factor: 3.553

Review 3.  Genetics of Borrelia burgdorferi.

Authors:  Dustin Brisson; Dan Drecktrah; Christian H Eggers; D Scott Samuels
Journal:  Annu Rev Genet       Date:  2012-09-04       Impact factor: 16.830

4.  Characterization of the physiological requirements for the bactericidal effects of a monoclonal antibody to OspB of Borrelia burgdorferi by confocal microscopy.

Authors:  R Escudero; M L Halluska; P B Backenson; J L Coleman; J L Benach
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

5.  Transformation of cystic forms of Borrelia burgdorferi to normal, mobile spirochetes.

Authors:  O Brorson; S H Brorson
Journal:  Infection       Date:  1997 Jul-Aug       Impact factor: 3.553

6.  In vitro conversion of Borrelia burgdorferi to cystic forms in spinal fluid, and transformation to mobile spirochetes by incubation in BSK-H medium.

Authors:  O Brorson; S H Brorson
Journal:  Infection       Date:  1998 May-Jun       Impact factor: 3.553

7.  Borrelia burgdorferi, the Lyme disease spirochete, possesses genetically-encoded responses to doxycycline, but not to amoxicillin.

Authors:  Timothy C Saylor; Timothy Casselli; Kathryn G Lethbridge; Jessamyn P Moore; Katie M Owens; Catherine A Brissette; Wolfram R Zückert; Brian Stevenson
Journal:  PLoS One       Date:  2022-09-30       Impact factor: 3.752

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.